Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00954915
Brief Title: Safety Study of the Monoclonal Antibody Teplizumab (MGA031) in Subjects With Moderate or More Severe Psoriasis

First Submitted : August 4, 2009
First Submitted that Met QC Criteria : August 6, 2009
First Posted : August 7, 2009 (Estimate)

Results First Submitted : March 27, 2012
Results First Submitted that Met QC Criteria : March 27, 2012
Results First Posted : April 19, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : August 20, 2012
Last Update Posted : August 30, 2012 (Estimate)